Gene · 1844
Papers2,214
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,214
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia. | Pharmaceuticals (Basel) | 2022 | 36558895 | PubTator, text mining | PubMed |
| Molecular signatures in the progression of COVID-19 severity. | Sci Rep | 2022 | 36543855 | PubTator, text mining | PubMed |
| Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis. | Med Oncol | 2022 | 36538194 | PubTator, text mining | PubMed |
| Transcription factor GATA6 promotes migration of human coronary artery smooth muscle cells in vitro. | Front Physiol | 2022 | 36523548 | PubTator, text mining | PubMed |
| Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma. | Front Med (Lausanne) | 2022 | 36507493 | PubTator, text mining | PubMed |
| Nasal administration of anti-CD3 monoclonal antibody modulates effector CD8+ T cell function and induces a regulatory response in T cells in human subjects. | Front Immunol | 2022 | 36505477 | PubTator, text mining | PubMed |
| Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation. | Front Immunol | 2022 | 36505452 | PubTator, text mining | PubMed |
| Investigating microRNAs to Explain the Link between Cholesterol Metabolism and NAFLD in Humans: A Systematic Review. | Nutrients | 2022 | 36500981 | PubTator, text mining | PubMed |
| Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation. | Front Cardiovasc Med | 2022 | 36465448 | PubTator, text mining | PubMed |
| Recent miRNA Research in Asthma. | Curr Allergy Asthma Rep | 2022 | 36459329 | PubTator, text mining | PubMed |
| Leiomyoma with Bizarre Nuclei: A Current Update. | Int J Womens Health | 2022 | 36457718 | PubTator, text mining | PubMed |
| Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes. | Nat Commun | 2022 | 36443294 | PubTator, text mining | PubMed |
| Krüppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells. | Sci Adv | 2022 | 36427304 | PubTator, text mining | PubMed |
| Expression and regulatory characteristics of peripheral blood immune cells in primary Sjögren's syndrome patients using single-cell transcriptomic. | iScience | 2022 | 36425764 | PubTator, text mining | PubMed |
| Phosphorylation of the smooth muscle master splicing regulator RBPMS regulates its splicing activity. | Nucleic Acids Res | 2022 | 36408906 | PubTator, text mining | PubMed |
| Alzheimer's disease alters the transcriptomic profile of natural killer cells at single-cell resolution. | Front Immunol | 2022 | 36405736 | PubTator, text mining | PubMed |
| Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis. | Mol Med | 2022 | 36401163 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy. | SAGE Open Med | 2022 | 36385790 | PubTator, text mining | PubMed |
| Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness. | Exp Mol Med | 2022 | 36380017 | PubTator, text mining | PubMed |
| Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents. | Signal Transduct Target Ther | 2022 | 36379915 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1844/papers?page=17